Zaprinast, but not CXCL17, is able to promote interactions between β-arrestin-2 and isoforms and species orthologs of GPR35. Following coexpression of C-terminally eYFP-tagged forms of human GPR35a (A), human GPR35B (B), mouse (C), or rat (D) GPR35 and Renilla luciferase-tagged β-arrestin-2, the indicated concentrations of the GPR35 agonist zaprinast (filled symbols) or CXCL17 (open symbols) were added, and induced interactions between GPCR35 and β-arrestin-2 were assessed 5 min later by measuring bioluminescence resonance energy transfer.